Plain-English translation of NCT07211139 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying tumor samples from patients with advanced head and neck cancer who have been treated with immune checkpoint inhibitors — medications that help the immune system fight cancer. By analyzing these tissue samples in detail, the team hopes to discover which patients are most likely to benefit from this medication and which ones may need different treatment approaches.
Currently, doctors cannot reliably predict which patients will respond well to immune therapy for head and neck cancer. While this treatment helps some people, it only works for about 15–26% of patients. This study aims to identify new markers in tumor tissue that could help doctors choose the right treatment for each patient from the start.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will review your existing tumor tissue samples that were already collected during your cancer care at Samsung Medical Center. They will analyze these samples in detail to understand how your immune system is responding to treatment. You will not need to undergo additional procedures or visits — the study uses tissue that was already obtained as part of your medical care.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
South Korea